(Q74623160)

English

Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with in vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785)

scientific article published on 01 April 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with in vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785) (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

ChEBI release 2020-05-28

Douglas B. Kitchen

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

C M Discafani

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

M L Carroll

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

M B Floyd

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

I J Hollander

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Z Husain

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

B D Johnson

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

M K May

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

M S Malo

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

A A Minnick

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

R Nilakantan

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

R Shen

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Y F Wang

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

A Wissner

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

L M Greenberger

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

language of work or name

0 references

publication date

1 April 1999

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Biochemical Pharmacology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

57

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

917-925

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

The type 1 (EGFR-related) family of growth factor receptors and their ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

Signaling through scaffold, anchoring, and adaptor proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

Receptor blockade with monoclonal antibodies as anti-cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

A potent protein-tyrosine kinase inhibitor which selectively blocks proliferation of epidermal growth factor receptor-expressing tumor cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

Tyrosine kinase inhibition: an approach to drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

A specific inhibitor of the epidermal growth factor receptor tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

Epidermal growth factor receptor tyrosine kinase. Investigation of catalytic mechanism, structure-based searching and discovery of a potent inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

Epidermal-growth-factor-dependent activation of the src-family kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

Inhibition of the epidermal growth factor receptor tyrosine kinase by PD153035 in human A431 tumors in athymic nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

In vivo pharmacology and anti-tumour evaluation of the tyrphostin tyrosine kinase inhibitor RG13022.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

Crystal Structure of the Catalytic Subunit of Cyclic Adenosine Monophosphate-Dependent Protein Kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

Structural features that specify tyrosine kinase activity deduced from homology modeling of the epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

New colorimetric cytotoxicity assay for anticancer-drug screening

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

Tyrosine kinase inhibitors. 11. Soluble analogues of pyrrolo- and pyrazoloquinazolines as epidermal growth factor receptor inhibitors: synthesis, biological evaluation, and modeling of the mode of binding

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

Evaluation of glucocorticoid-induced DNA fragmentation in mouse thymocytes by flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification 1

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2898%2900356-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-2952(98)00356-6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10086326%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74623160&oldid=2083399260"